Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3‑month efficacy and safety study of SVS20 in moderate bilateral dry eye syndrome
2007-001708-19Phase 3Completed
- Sponsor
- TRB Chemedica
- Start
- Aug 2007
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of SVS20 in dry eye syndrome (DED) and Sjögren's syndrome (3 arms), sponsored by TRB Chemedica. Started Aug 2007; status: completed.
02
Drugs
SVS20
03
Conditions
dry eye syndrome (DED)Sjögren's syndrome
Beyond the preview
Go deeper on 2007-001708-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001708-19.